Myomo to Report Fourth Quarter and Year End 2017 Results on March 7, 2018
February 28 2018 - 8:00AM
Business Wire
Management to hold a conference call at 4:30
p.m. EST
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a
commercial stage medical robotics company, today announced that it
will release its financial results for the fourth quarter and year
end December 31, 2017 results on Wednesday, March 7, 2018, after
the US markets close.
The Company will host a conference call on Wednesday, March 7,
2018 at 4:30 p.m. EST featuring remarks by Paul R. Gudonis,
Chairman and Chief Executive Officer, and Ralph Goldwasser, Chief
Financial Officer. The conference call will be available via
webcast and can be accessed through Myomo’s Investor Relations
page. Please allow extra time prior to the call to visit the site
and download any necessary software to listen to the live
broadcast.
To dial into the conference call, please dial 1-877-270-2148
from the U.S. or 1-412-902-6510 internationally. Please instruct to
be joined into Myomo’s earnings conference call. A replay of the
conference call will be available approximately one hour after
completion of the live conference call at the Investor Relations
page. A dial-in replay of the call will be available until March
21, 2018; please dial 1-877-344-7529 from the U.S. or
1-412-317-0088 internationally and provide the passcode of
10117217.
About MyomoMyomo, Inc. is a commercial stage medical
robotics company that offers expanded mobility for those suffering
from neurological disorders and upper limb paralysis. Myomo
develops and markets the MyoPro product line. MyoPro is a powered
upper limb orthosis designed to support the arm and restore
function to the weakened or paralyzed arms of patients suffering
from CVA stroke, brachial plexus injury, traumatic brain or spinal
cord injury, ALS or other neuromuscular disease or injury. It is
currently the only marketed device that, sensing a patient’s own
EMG signals through non-invasive sensors on the arm, can restore an
individual’s ability to perform activities of daily living,
including feeding themselves, carrying objects and doing household
tasks. Many are able to return to work, live independently and
reduce their cost of care. Myomo is headquartered in Cambridge,
Massachusetts, with sales and clinical professionals across the
U.S. For more information, please visit www.myomo.com.
Forward Looking StatementsThis press release contains
forward-looking statements regarding the Company's future business
expectations, which are subject to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements are only predictions and may differ
materially from actual results due to a variety of factors. Our
actual results could differ materially from those anticipated in
these forward looking statements for many reasons, including,
without limitation, risks related to regulatory approval and market
acceptance of our products, and the other risk factors contained in
our filings made with the Securities and Exchange Commission. More
information about factors that potentially could affect Myomo's
financial results is included in Myomo's filings with the
Securities and Exchange Commission. The Company cautions readers
not to place undue reliance on any such forward-looking statements,
which speak only as of the date made. The Company disclaims any
obligation subsequently to revise any forward-looking statements to
reflect events or circumstances after the date of such statements
or to reflect the occurrence of anticipated or unanticipated
events.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180228005168/en/
For Myomo:ir@myomo.comorInvestor Relations:PCG
AdvisoryVivian Cervantes,
646-863-6274vivian@pcgadvisory.comorPublic
Relations:GreenoughRachel Robbins,
617-275-6521rrobbins@greenough.biz
Myomo (AMEX:MYO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Myomo (AMEX:MYO)
Historical Stock Chart
From Apr 2023 to Apr 2024